May 27, 2014
GlaxoSmithKline K.K. (GSK) launched the antiviral chemotherapeutic agent Tenozet Tablets 300 mg (tenofovir disoproxil fumarate) on May 23. The drug is a nucleotide analog originally developed by Gilead Sciences of the US. GSK has acquired exclusive rights to develop and...read more